Bortezomib
A pyrazine and boronic acid derivative that functions as a reversible PROTEASOME INHIBITOR. It is used as an ANTINEOPLASTIC AGENT in the treatment of MULTIPLE MYELOMA and MANTLE CELL LYMPHOMA.
Year introduced: 2016 (2000)
PubMed search builder options
Subheadings:
Tree Number(s): D01.029.260.110.500, D01.132.285.500, D02.203.200.500, D03.383.679.450
MeSH Unique ID: D000069286
Registry Number: 69G8BD63PP
Entry Terms:
- PS 341
- 341, PS
- PS-341
- PS341
- Velcade
- LDP-341
- LDP341
- LDP 341
Pharmacologic Action: